Physicochemical stability of cimetidine amorphous forms estimated by isothermal microcalorimetry

AAPS PharmSciTech

Volumn 3, Issue 4, 2002, Pages

  Otsuka, Makoto ^a   Kato, Fumie ^a   Matsuda, Yoshihisa ^a  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Amorphous; Cimetidine; Crystalization; Isothermal microcalorimetry; Physicochemical stability

Indexed keywords

CIMETIDINE;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG STABILITY; HUMIDITY; ISOTHERM; MICROCALORIMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSICAL CHEMISTRY; THERMOSTABILITY; X RAY DIFFRACTION; CHEMISTRY; DRUG STORAGE; KINETICS; METHODOLOGY; PHARMACEUTICS; POWDER; SCANNING ELECTRON MICROSCOPY; TIME; X RAY CRYSTALLOGRAPHY;

CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CHEMISTRY, PHYSICAL; CIMETIDINE; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; DIFFERENTIAL THERMAL ANALYSIS; DRUG STABILITY; DRUG STORAGE; HUMIDITY; KINETICS; MICROSCOPY, ELECTRON, SCANNING; POWDERS; TECHNOLOGY, PHARMACEUTICAL; TIME FACTORS;

EID: 23144458316     PISSN: 15309932     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt030430     Document Type: Article

References (22)

1. Food and Drug Administration. Guidelines: manufacturing and controls for INDs and NDAs. Quoted by:Pharm Tech Japan. 1985;1:835-850.
2. Haleblian JK. Characterization of habits and crystalline modification of solids and their pharmaceutical applications. J Pharm Sci. 1975;64:1269-1288.
3. Otsuka M, Matsuda Y. Polymorphism, pharmaceutical aspects. In: Swarbrick J, Boylan JC, eds. Encyclopedia of Pharmaceutical Technology. Vol 12. New York, NY: Marcel Dekker; 1995:305-326.
4. Briggner L, Buckton G, Bystrom K, Darcy P. The use of isothermal microcalorimetry in the study of changes in crystallinity induced during the processing of powders. Int J Pharm. 1994;105:125-135.
5. Sebhatu T, Angberg M, Ahlneck C. Assessment of the degree of disorder in crystalline solids by isothermal microcalorimetry. Int J Pharm. 1994;104:135-144.
6. Angberg M, Nyström C, Castensson S. Evaluation of heat-conduction microcalorimetry in pharmaceutical stability studies, V: a new approach for continuous measurements in abundant water vapour. Int J Pharm. 1992;81:153-167.
7. Sheridan PL, Buckton G, Storey DE. Development of a flow microcalorimetry method for the assessment of surface properties of powders. Pharm Res. 1995;12:1025-1030.
8. Buckton G, Darcy P, Greenleaf D, Holbrook P. The use of isothermal microcalorimetry in the study of changes in crystallinity of spraydried s albutamol sulphate. Int J Pharm. 1995;116:113-118.
9. Aso Y, Yoshioka S, Otsuka T, Kojima S. The physical stability of amorphous nifedipine determined by isothermal microcalorimetry. Chem Pharm Bull. 1995;43:300-303.
10. Rat M, Guillaume P, Wilker S, Pantel G. Practical application of microcalorimetry to the stability of propellants. Workshop Microcalorim Energ Mater. Defence Research Agency: Sevenoaks, UK. 1997;V1-V18.
11. Mimura H, Kitamura S, Koda S. Evaluation of drug stability by isothermal microcalorimetry. Netsu Sokutei. 1998;25(4):92-96.
12. Giron D. Thermal analysis, microcalorimetry and combined techniques for the study of pharmaceuticals. J Therm Anal Calorim. 1999;56(3):1285-1304.
13. Du W, Li X, Wang B, Zhang Y. A study on the interaction between cisplatin and urease. Thermochim Acta. 1999;333(2):109-114.
14. Beezer A, Gaisford S, Hills AK, Mitchell JC. Pharmaceutical microcalorimetry: applications to long-term stability studies. Int J Pharm. 1999;179(2):159-165.
15. Runge FE, Heger R. Use of microcalorimetry in monitoring stability. Example: vitamin A esters. J Agric Food Chem. 2000;48(1):47-55.
16. Tompa AS Jr, Bryant WF. Microcalorimetry and DSC study of the compatibility of energetic materials. Proc Workshop Microcalorim Energ Mater 2nd. Defence Research Agency: Sevenoaks, UK. 1999;Q1-Q21.
17. Phipps MA, Mackin LA. Application of isothermal calorimetry in solid state drug development. Pharm Sci Technol Today. 2000;3(1):9-17.
18. Shibata M, Kokubo H, Morimoto K, Morisaka K, Ishida T, Inoue M. X-ray structural studies and physicochemical properties of cimetidine polymorphism. J Pharm Sci. 1983;72:1436-1442.
19. Hegedüs B, Görög S. The polymorphism of cimetidine. J Pharm Biomed Anal. 1985;3:303-313.
20. Hancock JD, Sharp JH. Method of comparing solid-state kinetic data and its application to the decomposition of kaolinite, brucite, and BaCO3. J Am Ceram Soc. 1972;55:74-77.
21. Otsuka M, Kaneniwa N. Dehydration of cephalexin hydrates. Chem Pharm Bull. 1983;31:1021-1029.
22. Tanigawara Y, Yamakoka K, Nakagawa T, Uno T. Moment analysis for the separation of mean in vivo disintegration, dissolution, absorption, and disposition time of ampicillin products. J Pharm Sci. 1982;71(10):1129-1133.